A new Health Canada report outlines recommendations & first steps to guide Canada’s Drug Agency (CDA) in leading and implementing a pan-Canadian strategy to improve the appropriate use of medications. The report says it clearly: "There is no one group that can move the bar on

Emily McDonald This will put me in the minority but I think most cases of categorical exclusions for pregnancy in clinical trials are unethical, because they’re not based in reasonable evidence/expectation that the risk:benefit calculus of randomization is less favorable for a pregnant woman.

Emily McDonald Pregnancy would not alter my recommendation about Rifampin. Shared decision making would be best approach (as always) If it were TB, you would insist on the Rifampin. How much you recommend any drug to a pregnant person depends on the benefit. Would NOT exclude from trials.

ICYMI - #Deprescribing webinar recording! When making decisions about 🛑#statins, consider: ✅pt values, preferences, health status ✅current evidence 👉🏽Watch as Wade Thompson summarizes current evidence on deprescribing statins: tiny.cc/StatinDeprescr…

Share your medication story with our network! ⬇️📯🗣️🎙️

Wide-spectrum #antibiotics don't always have the worst collateral effects on gut #microbiome & vice-versa: #CMICommunications review on antibiotics' selection of ESKAPE pathogens (Flury et al.) doi.org/10.1016/j.cmic… ESCMID HUG #IDTwitter #idxposts #stewardship #openaccess

Study: Polypharmacy Nearly Doubled in 20 Years Among Older Adults in US Marker of multimorbidity epidemiology (and over medicalisation- the two are hard to seperate) jamanetwork.com/journals/jama/…

Gabby Librizzi, MD, MPH Article coming soon on ESR/CRP. Hoping to the end the madness…

Next #Communicable podcast release Mon 12 Aug: "Melioidosis goes global" Joshua Davis & Angela welcome experts Ella Meumann & Bart Currie for a clinical & epidemiological update on #melioidosis (approach-to concise review: ow.ly/B7iM50SR7YS) #IDtwitter #idxtwitter ESCMID

#DYK only 5% of eligible patients participate in clinical trials, yet these trials are crucial for developing new treatments. Without participation, we can't advance medical science as quickly. Learn more surprising facts and why you should consider participating. 🔎💜

GABA-WHY followed by GABA-DON’T Offer #deprescribing to your patient and make use of our patient brochures freely available online. CADeN

Booking my flights to Antarctica now… Have a listen to our #Communicable podcast on Candida auris First episode in our nightmare series 😱 CMI Communications

Our latest #Communicable podcast episode on #Candidaauris drops on Monday. We are so excited for it, we wanted to share a little teaser! Emily McDonald Jeffrey M. Rybak PharmD, PhD ESCMID Need more now? Listen to our previous episodes communicable.transistor.fm/episodes #IDtwitter #IDxposts

★ Just published: #Communicable podcast episode "The Nightmare Series, part 1: how to deal with Candida auris" Kicking off the series our hosts Emily McDonald & Nav invite experts Jeffrey M. Rybak PharmD, PhD & Graham Snyder to elaborate on #Candidaauris share.transistor.fm/s/c0616c4d #IDtwitter #idxposts

Wow. It's published! Our new article that will spark some good active discussion among ID people! 🆕️🔥 Clinical Microbiology and Infection by ID master Brad Spellberg & 🌟s Todd C. Lee Emily McDonald Revisiting Diagnostics: ESR and CRP:It's Time to Stop the Zombie Tests clinicalmicrobiologyandinfection.com/article/S1198-…

"A patient who is eating a sandwich and feeling better on day three of a gastroenteritis hospitalization may be kept in the hospital for a CRP value of 150. In contrast, a patient with wet gangrene of the fifth toe might be sent home because the CRP value is only 5." 👌

Our latest funding opportunity connects ACT Networks with high-impact RCTs currently underway in other countries. Successful applicants will receive up to $200,000 to support Canadian recruitment. For more information visit: act-aec.ca/call-for-propo…

CADeN director Emily McDonald shared findings of an updated analysis of the cost of potentially inappropriate medications in Canada in 2021, and how they’ve changed since 2013. Curious? The publication is coming very soon 👀 CDA-AMC #CDA_AMC